Azenta, Inc. (AZTA) PT Raised to $59 at Needham
Needham analyst David Saxon raised the price target on Azenta, Inc. (NASDAQ: AZTA) to $59.00 (from $55.00) while maintaining a Buy rating.
The analyst commented: 'AZTA’s F1Q25 revenue and EPS both beat consensus while adj. EBITDA was in line with Street estimates. Excluding one-time items, adj. EBITDA would have been >10% which makes the reiterated margin guidance look conservative, in our view. SMS growth was driven by C&I and SRS while Multiomics growth was driven by NGS and gene synthesis. In the near-term, we believe guidance should leave room for upside and, an Investor Day over the summer, should provide more clarity on AZTA's growth and profitability potential over the longer-term. We reiterate our Buy rating and raise our price target to $59 (from $55) as we roll forward our valuation metric to CY26."